Division 1.2.8 Route of administration
United Kingdom
In the risk assessment, the manufacturer must take into account the route of administration as indicated in the product information.
Notes on Division 1.2
Textual amendments
- F1
Words in Annex 1 s. 1.2 substituted (11.8.2021) by The Medical Devices (Amendment) (EU Exit) Regulations 2021 (S.I. 2021/873), reg. 1(1), Sch. 2 para. 15(a)